menopause and microdosing glp 1 GLP-1 for Perimenopause: Why Lower Doses Might Be Better Microdosing for GLP-1s for Menopause-Related

Very educational on nutrition

Remember that packaging that emphasizes larger portion sizes or quantities could be a turn-off to GLP-1 patients seeking smaller portion sizes

Only one study did not identify any benefit of GLP-1RAs in animal models of opiate misuse, although this same study had shown a positive effect for alcohol misuse 63

Costs per user would decline over time, from $5,600 per person in 2026 to $4,300 per person in 2034, but are likely to be offset by increased uptake

Weight loss across this period was stratified by quartiles of engagement (Quartiles of average total app opens at 40 weeks: Q1 = 244.7 , Q4 = 2,162.2)

The primary outcome is the percentage of participants with absence of NASH with no worsening of fibrosis on liver histology [64]